ECAT Form 4: Saba Capital Reports Two Insider Sales (19,193 shares)
Saba Capital Management, L.P. reported two insider sales of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock.
Rhea-AI Filing Summary
Saba Capital Management, L.P. reported two insider sales of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock. On 09/30/2025 the reporting person sold 1,063 shares at $16.44, leaving 27,800,724 shares beneficially owned indirectly. On 10/01/2025 they sold 18,130 shares at $16.55, leaving 27,782,594 shares beneficially owned indirectly. The filer is identified as a Director and a 10% owner. The form is signed by Saba Capital Management, L.P., Zachary Gindes and Boaz Weinstein.
Positive
- None.
Negative
- Insider sales disclosed: The reporting person sold a total of 19,193 shares across 09/30/2025 and 10/01/2025.
- Reduction in beneficial ownership: Post-transactions beneficial holdings decreased from 27,800,724 to 27,782,594 shares (indirect).
Insights
TL;DR: Insider sales recorded by a director/10% owner; volumes are small relative to the total reported holdings.
The filing discloses two open-market sales totaling 19,193 shares across two days at prices of $16.44 and $16.55. Beneficial ownership remains large at over 27.7 million shares held indirectly, indicating the transactions were modest reductions of a substantial position. The disclosure is routine for Section 16 reporting and contains specific transaction dates, prices and post-transaction holdings.
TL;DR: Form 4 shows routine compliance-level disclosure of insider sales by an entity connected to the issuer.
The document identifies the reporting entity as a Director and a 10% owner, and provides signatures from the reporting firm and two individuals. It lists exact share counts and sale prices, satisfying Section 16 reporting requirements. No amendments, derivative transactions, or additional disclosures are present.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 18,130 | $16.55 | $300K |
| Sale | Common Stock | 1,063 | $16.44 | $17K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transactions does the ECAT Form 4 report show?
Who filed the Form 4 for ECAT?
What is the reporting person’s relationship to ECAT?
Are there any derivative transactions reported in this Form 4 for ECAT?
AI-generated analysis. How Rhea-AI works. Not financial advice.